Bashar Al-Turk

Bashar Al-Turk practices at Piedmont Heart Institute in Fayetteville, Georgia.

Bashar Al-Turk's NPI, 1699160408, was assigned on March 30, 2015. Bashar Al-Turk graduated from Lake Erie College of Osteopathic Medicine, Erie in 2015. Bashar Al-Turk holds Georgia license 91311.

Bashar Al-Turk's primary practice is Piedmont Heart Institute, at 1267 Highway 54 W, Fayetteville, GA 30214 in Fayette County. The practice phone is (404) 605-2800.

Bashar Al-Turk's primary practice is Piedmont Heart Institute in Fayetteville, Georgia. Bashar Al-Turk is also affiliated with Piedmont Fayette Hospital. The medical group on file is Piedmont Heart Institute. Dmand AI also links Bashar Al-Turk to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bashar Al-Turk practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Bashar Al-Turk's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Bashar Al-Turk's licenses on file in 2 states: Georgia and Florida.

CMS data shows 2,087 Medicare services from Bashar Al-Turk across 20 procedure codes in 2024, for 998 Medicare patients. Medicare paid $89,282 for them.

CMS counts 998 Medicare patients who saw Bashar Al-Turk in 2024. The largest group is 75 to 84, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bashar Al-Turk's median patient age at 63, with 56% women.

In 2024, Bashar Al-Turk wrote 2,812 Medicare Part D claims for 470 patients. 84% of them were for generic drugs. CMS names the drug for 2,626 of them, across 37 drugs with 11 or more claims each, at $519,924 in total drug cost. In 2023, CMS named 1,420 claims across 26 drugs.

Bashar Al-Turk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Bashar Al-Turk, published from 2017 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Coronary Vasospasm and Electrocardiography. Bashar Al-Turk's most frequent co-authors are Dominika Maria Zoltowska, MD, Monica Aggarwal, MD and Michael K. Chahin, DO.

CMS Open Payments shows 99 general payments to Bashar Al-Turk from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 89% of the total. Abbott Laboratories paid the most, $461.

Bashar Al-Turk graduated from Lake Erie College of Osteopathic Medicine, Erie in 2015.